| Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests RFA Logan, J Patnick, C Nickerson, L Coleman, MD Rutter, ... Gut 61 (10), 1439-1446, 2012 | 591 | 2012 |
| Distinct bone marrow-derived and tissue-resident macrophage lineages proliferate at key stages during inflammation LC Davies, M Rosas, SJ Jenkins, CT Liao, MJ Scurr, F Brombacher, ... Nature communications 4 (1), 1886, 2013 | 349 | 2013 |
| Suppression of tumour-specific CD4+ T cells by regulatory T cells is associated with progression of human colorectal cancer G Betts, E Jones, S Junaid, T El-Shanawany, M Scurr, P Mizen, M Kumar, ... Gut 61 (8), 1163-1171, 2012 | 183 | 2012 |
| Highly prevalent colorectal cancer-infiltrating LAP+ Foxp3− T cells exhibit more potent immunosuppressive activity than Foxp3+ regulatory T cells M Scurr, K Ladell, M Besneux, A Christian, T Hockey, K Smart, ... Mucosal immunology 7 (2), 428-439, 2014 | 156 | 2014 |
| COVID‐19 vaccine response in people with multiple sclerosis EC Tallantyre, N Vickaryous, V Anderson, AN Asardag, D Baker, ... Annals of neurology 91 (1), 89-100, 2022 | 142 | 2022 |
| Low-dose cyclophosphamide induces antitumor T-cell responses, which associate with survival in metastatic colorectal cancer M Scurr, T Pembroke, A Bloom, D Roberts, A Thomson, K Smart, ... Clinical Cancer Research 23 (22), 6771-6780, 2017 | 136 | 2017 |
| The Ussing chamber system for measuring intestinal permeability in health and disease A Thomson, K Smart, MS Somerville, SN Lauder, G Appanna, J Horwood, ... BMC gastroenterology 19, 1-14, 2019 | 107 | 2019 |
| Esterified eicosanoids are acutely generated by 5-lipoxygenase in primary human neutrophils and in human and murine infection SR Clark, CJ Guy, MJ Scurr, PR Taylor, AP Kift-Morgan, VJ Hammond, ... Blood, The Journal of the American Society of Hematology 117 (6), 2033-2043, 2011 | 101 | 2011 |
| T‐cell modulation by cyclophosphamide for tumour therapy E Hughes, M Scurr, E Campbell, E Jones, A Godkin, A Gallimore Immunology 154 (1), 62-68, 2018 | 70 | 2018 |
| Effect of modified vaccinia Ankara–5T4 and low-dose cyclophosphamide on antitumor immunity in metastatic colorectal cancer: A randomized clinical trial M Scurr, T Pembroke, A Bloom, D Roberts, A Thomson, K Smart, ... JAMA oncology 3 (10), e172579-e172579, 2017 | 61 | 2017 |
| Effect of modified vaccinia Ankara–5T4 and low-dose cyclophosphamide on antitumor immunity in metastatic colorectal cancer: A randomized clinical trial M Scurr, T Pembroke, A Bloom, D Roberts, A Thomson, K Smart, ... JAMA oncology 3 (10), e172579-e172579, 2017 | 61 | 2017 |
| Cytomegalovirus-Specific IL-10-Producing CD4+ T Cells Are Governed by Type-I IFN-Induced IL-27 and Promote Virus Persistence M Clement, M Marsden, MA Stacey, J Abdul-Karim, S Gimeno Brias, ... PLoS Pathogens 12 (12), e1006050, 2016 | 52 | 2016 |
| Magnitude of venous or capillary blood-derived SARS-CoV-2-specific T cell response determines COVID-19 immunity MJ Scurr, G Lippiatt, L Capitani, K Bentley, SN Lauder, K Smart, ... Nature communications 13 (1), 5422, 2022 | 42 | 2022 |
| Enhanced antitumor immunity through sequential targeting of PI3Kδ and LAG3 SN Lauder, K Smart, V Kersemans, D Allen, J Scott, A Pires, S Milutinovic, ... Journal for immunotherapy of cancer 8 (2), 2020 | 26 | 2020 |
| Assessing the prognostic value of preoperative carcinoembryonic antigen-specific T-cell responses in colorectal cancer MJ Scurr, CM Brown, DF Costa Bento, GJ Betts, BI Rees, RK Hills, ... Journal of the National Cancer Institute 107 (4), djv001, 2015 | 24 | 2015 |
| Escalating regulation of 5T4-specific IFN-γ+ CD4+ T cells distinguishes colorectal cancer patients from healthy controls and provides a target for in vivo therapy M Scurr, A Bloom, T Pembroke, R Srinivasan, C Brown, K Smart, ... Cancer immunology research 1 (6), 416-425, 2013 | 24 | 2013 |
| Response to COVID-19 booster vaccinations in seronegative people with multiple sclerosis EC Tallantyre, MJ Scurr, N Vickaryous, A Richards, V Anderson, D Baker, ... Multiple Sclerosis and Related Disorders 64, 103937, 2022 | 20 | 2022 |
| Whole blood‐based measurement of SARS‐CoV‐2‐specific T cells reveals asymptomatic infection and vaccine immunogenicity in healthy subjects and patients with solid‐organ cancers MJ Scurr, WM Zelek, G Lippiatt, M Somerville, SEA Burnell, L Capitani, ... Immunology 165 (2), 250-259, 2022 | 19 | 2022 |
| T cell subsets and colorectal cancer: discerning the good from the bad M Scurr, A Gallimore, A Godkin Cellular Immunology 279 (1), 21-24, 2012 | 19 | 2012 |
| Persistent COVID-19 Infection in Wiskott-Aldrich syndrome cleared following therapeutic vaccination: a case report RE Bradley, MJ Ponsford, MJ Scurr, A Godkin, S Jolles, ... Journal of Clinical Immunology 42 (1), 32-35, 2022 | 14 | 2022 |
